A Phase II Open-Label, International Multi-Center Study of a Group B Streptococcus Polysaccharide Conjugate Vaccine Administered Intramuscularly to HIV Positive and HIV Negative Pregnant Women.

Trial Profile

A Phase II Open-Label, International Multi-Center Study of a Group B Streptococcus Polysaccharide Conjugate Vaccine Administered Intramuscularly to HIV Positive and HIV Negative Pregnant Women.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 May 2016

At a glance

  • Drugs Streptococcal B vaccine conjugate (Primary)
  • Indications Streptococcal infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Novartis; Novartis Vaccines
  • Most Recent Events

    • 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Nov 2012 Planned End Date changed from 1 Nov 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 10 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top